As 2025 comes to a close, it is clear that this has been a defining year for Glooko and for the broader evolution of diabetes care. Following the close of our Series F, we entered the year with a clear focus: deliver on our strategy, expand our global impact, and continue building technology that helps make diabetes care more connected, actionable, and human.

Accelerating our Mission through Strategic Leadership and a Connected Care Continuum

Over the past year, we reached several important milestones in support of that goal. We expanded our capabilities through the acquisition of Monarch Medical Technologies and its EndoTool Glucose Management System, bringing together complementary capabilities across outpatient and inpatient diabetes and glycemic management.

We strengthened our ecosystem with the launch of our Abbott FreeStyle Libre integration in the U.S., helping ensure that critical glucose data can flow more seamlessly to people with diabetes and their care teams.

We also reinforced our clinical leadership with the appointment of Mark Clements, M.D., Ph.D., as Chief Medical and Strategy Officer, underscoring our commitment to evidence-based innovation and strong clinical partnership.

Driving Digital Health Adoption in EMEA

We also saw meaningful traction across geographies and care settings.

In EMEA, we continued to expand our presence as health systems look for scalable, interoperable digital solutions to support diabetes care. At the same time, Glooko XT, our remote monitoring solution available only in France, introduced new features and strengthened its gestational diabetes management capability, an area where timely insights and coordinated care are critical for both maternal and fetal outcomes. These areas of momentum reflect the growing demand for digital tools that can support diverse patient populations and clinical workflows.

Further Enhancing our Diabetes Management Platform to Improve Care

On the product front, we continued to invest in tools designed for the realities of care delivery.

The launch of the new Glooko clinic dashboard marked an important step forward in helping clinics and health systems move beyond raw data to clearer insights, enabling more informed, timely decisions at the point of care. Across the organization, we remained focused on bringing teams together around a shared mission and shared standards, ensuring that our growth continues to be purposeful and aligned.

A reality faced by care teams each day is the need for timely, actionable data within existing clinical workflows. That’s why we invested further into our EHR capabilities this year and joined the Epic Showroom to make it easier for hospitals and health systems to seamlessly integrate their EHR with Glooko, helping reduce clinician burnout and optimize clinical workflows.

The Glooko Mobile App for people with diabetes also continued to innovate in 2025 with a redesigned food tracker for more insightful nutrition data and insights, revised insulin cards for more clarity, and viewable GLP-1 doses. These enhancements enable care teams to make more informed and timely treatment decisions between appointments using their patients’ health data – all viewable in one place.

How the U.S. Healthcare System is Moving Toward Data-Driven, Accountable Diabetes Care

These milestones matter, but they are occurring against a broader backdrop of change in healthcare that strongly validates this direction. The latest American Diabetes Association’s Standards of Care reinforce what clinicians and people with diabetes have long understood: technology-enabled management and data-driven insights are now foundational to delivering high-quality diabetes care.

At the same time, policy initiatives such as the CMS ACCESS program signal a growing emphasis on interoperability, data liquidity, and the responsible use of health data to improve outcomes at scale.

Together, these shifts point to a future in which diabetes care is increasingly proactive rather than reactive, and where data is not simply collected, but translated into meaningful action.

Regulatory momentum is reinforcing the importance of consistent, evidence-based glycemic management across care settings. CMS’s upcoming electronic clinical quality measure (eCQM) requirements for inpatient glycemic management, expected to take effect in 2026, reflect a growing emphasis on standardization, measurement, and accountability in hospital-based diabetes care. Solutions like EndoTool are at the forefront of this shift, helping health systems operationalize best practices, support clinical decision-making, and drive more reliable glycemic outcomes at scale.

For healthcare providers and care teams, this evolution brings both opportunity and urgency. As care becomes more continuous and data-rich, success depends on having tools, like Glooko’s EHR integrations, that reduce complexity, surface what matters most, and fit naturally into clinical workflows. The goal is not more data for its own sake, but clearer insight that supports better decisions and more personalized care.

For health systems, the focus is expanding to population-level impact. Managing chronic disease across diverse populations requires platforms that enable earlier intervention, more consistent care, and coordination across settings. Interoperable digital solutions, like Glooko, are becoming essential infrastructure for balancing quality, efficiency, and cost in an increasingly complex care environment.

Leveraging Scalable Healthcare Technology to Deliver Consistent Diabetes Care Around the World

Globally, the stakes are even higher. Diabetes prevalence continues to rise across regions with very different healthcare resources and delivery models. Scalable digital health solutions offer a path to extend evidence-based care, support clinicians, and bring greater consistency to diabetes management worldwide. As global standards and policies evolve, technology will play a central role in enabling more equitable access to high-quality care.

The Road Ahead for Glooko

Looking ahead, our focus at Glooko remains clear. We will continue investing in platforms that turn diabetes data into insight, insight into action, and action into better outcomes. We will deepen partnerships across the ecosystem and stay closely aligned with clinicians, health systems, and people with diabetes as their needs continue to evolve.

2025 was a year of momentum for Glooko. More importantly, it reinforced why our mission matters. As the future of diabetes care continues to take shape, we are energized by the opportunity to help lead the way.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.

Healthcare providers struggle to manage large diabetes populations without a comprehensive view of patient data.

During this webinar, Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, and Glooko Senior Clinical Transformation Director Trisha Martinez, BSN, MBA, RN, explore the new Glooko clinic dashboard, a powerful tool designed to streamline diabetes population health management and enable smarter care across hospitals, health systems, and clinics.

Our clinical experts take a deep dive into this user-friendly dashboard, available in select countries, and showcase its at-a-glance insights into patient trends and key clinic metrics that can help care teams easily interpret complex data for more efficient decision-making.

Ready to optimize diabetes population health management?

Contact Team Glooko for a demo of our new clinic dashboard, which helps healthcare teams manage large diabetes populations more effectively by prioritizing care and boosting patient engagement.

MKT-0468

During this Glooko 101 webinar, Glooko Senior Director of Clinical Transformation Trisha Martinez, BSN, MBA, RN, helps healthcare providers, including endocrinologists, nurses, and certified diabetes care and education specialists, get the most out of their professional Glooko account, reviewing core features and tools that support clinical workflows for both new users and those looking for a refresher.

This session also covers best practices for onboarding patients with diabetes using continuous glucose monitors (CGMs), including how to connect CGM data to Glooko to ensure seamless access to glucose trends and actionable insights from day one.

Time to Optimize your Diabetes Practice

Book a one-on-one session with Team Glooko today to better understand how to optimize Glooko from the start, get customized guidance on connecting CGM data, and gain access to actionable glucose trends care teams need.

MKT-0473

The role of certified diabetes care and education specialists (CDCESs) is vital in helping people with diabetes manage their condition, achieve optimal health outcomes, and thrive.

Glooko’s innovative web platform and mobile app is designed to make diabetes care and education more efficient, data-driven, and impactful for these critical care team members.

By providing cutting-edge capabilities, Glooko empowers CDCESs at hospitals, health systems, and clinics to support patients’ diabetes management, reduce the risk of complications, and improve health outcomes.

Advantages of CDCESs Leveraging Glooko

Glooko offers a range of features in its platform that streamlines clinical workflows, enhances the decision-making for CDCES professionals and the entire diabetes care team, and ultimately, supports better diabetes management and care:

• Expansive Device Compatibility: Glooko seamlessly integrates with over 200 diabetes and health monitoring devices and apps, centralizing relevant health data and making it easily accessible.
• Clinic Dashboard for Diabetes Population Health Management: Our new clinic dashboard, available in select countries, provides CDCESs with at-a-glance insights of a clinic’s diabetes patient population, leading to more efficient, data-driven decisions.
• Seamless EHR Integrations: Our integrations with leading electronic health records (EHRs), including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, securely centralizes diabetes and related health data, giving CDCESs a complete view of a patient’s health in one place and eliminating the hassle of platform switching and multiple logins.
• Educational Digital Care Programs: Glooko’s care programs complement the work of the CDCES by providing patients with structured education that advances their understanding of diabetes management.
• Easier Log-in with SSO: Single Sign-On (SSO) eliminates the need for multiple logins and passwords, cutting credential hassle so CDCESs can focus more time on delivering high-quality patient care.
• Exceptional Customer Support: Backed by rapid response times, an extensive help center, and U.S.-based support, CDCESs can spend less time troubleshooting technical issues and more time focused on their patients.

Glooko Advances the ADCES7 Self-Care Behaviors®

Diabetes Self-Management Education and Support (DSMES) is a program from the Association of Diabetes Care and Education Specialists (ADCES) designed to empower individuals with diabetes to manage their condition effectively. It’s structured around the ADCES7 Self-Care Behaviors, which represent seven critical areas of diabetes self-management.

CDCES professionals partner with patients with diabetes to help prioritize and improve their own management skills across these seven essential behaviors. CDCESs can leverage the Glooko Mobile App, which supports patients in tracking and managing each of these behaviors, to complement their own education and guidance:

• Healthy Eating: People living with diabetes can enter food into the Glooko Mobile App to better understand how nutrition affects their condition and well-being.
• Being Active: The app allows tracking of steps, fitness, and other exercises, helping users understand the impact of physical activity on their overall health and glycemic control.
• Taking Medication: Patients can track medication, set reminders, and enter notes about the impact of medications, which can be shared with care teams.
• Reducing Risk: Through its manual entry feature and compatibility with smart scales and blood pressure cuffs, the Glooko Mobile App can be used to monitor trends in weight and blood pressure.
• Problem Solving: The app helps users identify patterns in everything from nutrition and weight to insulin and glucose levels and solve challenges independently or through remote collaboration with their car team.
• Healthy Coping: People with diabetes can record notes in the Glooko Mobile App about their feelings, beliefs, challenges, and successes while managing their diabetes.

Users of the Glooko Mobile App also can access our comprehensive support center for troubleshooting and helpful tips, allowing them to make the most of the app’s features.

Enhance the CDCES-Patient Experience with Glooko

At Glooko, we provide CDCES professionals with digital health tools for simpler diabetes management and better health outcomes for their patients.

Find out how Glooko’s diabetes management software can support your care team’s delivery of data-driven, high-quality care by scheduling a demo.

October is Cybersecurity Awareness Month, but for Glooko, the only diabetes management company with multiple industry-leading security certifications, our commitment to protecting patient health data is a year-round mission.

According to Glooko CEO Mike Alvarez, one of our diabetes management company’s core differentiators is our commitment to patient safety and data privacy, which enables us to build and maintain trust with hospitals, health systems, clinics, and people living with diabetes.

As the healthcare industry faces rising cyberattacks, Glooko understands that securing health data and ensuring the security and privacy of this sensitive information is not just a policy — it’s a core responsibility.

Building a Foundation of Trust Through Security Certifications

Security isn’t a single feature you can switch on; it’s a comprehensive framework built on continuous commitment, sophisticated technology, and rigorous auditing.

As the most secure diabetes management platform, Glooko has invested heavily in achieving and maintaining a number of rigorous global security certifications and standards, which serve as a powerful testament to the maturity and diligence of our security practices that safeguard the sensitive personal and health data of our users with diabetes.

Here are the key standards and certifications that build Glooko’s security backbone:

• ISO 27001: This globally recognized information security management standard outlines requirements for an information security management system (ISMS). Achieving this certification means an organization has a systematic approach to managing sensitive company and customer information.
• SOC 2 Type II and SOC 3 Certification: These internationally recognized global reporting standards, validated by an auditing firm, verify that Glooko’s controls across its employees, systems, and processes fully secure all customer data, software, and company assets.
• HITRUST Risk-based, 2-year (r2) Certification: Achieving this healthcare industry gold standard confirms our stringent, independently-audited security controls meet the highest requirements of frameworks like HIPAA and NIST. This places us in an elite group dedicated to protecting sensitive patient health data. Explore our recent study on strengthening our cyber resilience…
• HIPAA Compliance: This U.S. federal law ensures the protection of sensitive patient health information from being disclosed without the patient’s consent or knowledge.
• The NHS Digital Data Security and Protection Toolkit (DSPT): For operations in the U.K., this framework ensures that patient data is handled securely and in a way that respects privacy.
• GDPR: This comprehensive European Union law gives individuals control over their personal data by setting strict rules for how organizations worldwide must collect, process, and protect that information.

How Diabetes Patient Health Data is Protected on a Day-to-Day Basis

Beyond the certifications, hundreds of controls are implemented to ensure data remains secure at Glooko. Our approach, covering protection, defense, response, and recovery, includes:

• Continuous Vulnerability Management: Regular penetration testing and vulnerability scans are conducted to proactively identify and address potential weaknesses in their systems.
• Internal Governance: A dedicated governance board oversees our diabetes management company’s policies, ensuring that security and privacy are considered in all decisions.
• Employee Training: A core element of any security strategy is the people. Team Glooko receives regular, mandatory training on data security and privacy protocols.
• Privileged Access Management: Policies are in place to ensure that only authorized personnel have access to sensitive information.
• Secure Software Development Lifestyle (SSDLC): Security code reviews, threat modeling, and static and dynamic code scans are completed during the software development lifecycle

Your Data, Your Control

A crucial part of data privacy is the user’s right to control their information. We make it clear that personally identifiable data is never shared without explicit consent. When using the platform through a healthcare provider, Glooko functions as a part of the healthcare provider’s operations, always adhering to the same stringent privacy standards.

Our Constant Commitment to Protecting Patient Safety

Cybersecurity Awareness Month is a great starting point, but data protection requires constant, evolving, and year-round efforts because threats are always changing.

Through a combination of robust technical controls, a culture of security, and adherence to global standards, Glooko’s commitment to trust and privacy is a fundamental part of our connected care company beyond October.

When healthcare professionals manage a large population of patients with diabetes, they often lack a clear, organized, and comprehensive view of patients’ pertinent health data.

To help address this challenge, we designed the new clinic dashboard in the Glooko diabetes management platform. Available in select countries, the dashboard helps healthcare providers, including primary care providers, endocrinologists, and nurses, at hospitals, health systems, and clinics streamline their diabetes population health management.

Developed for busy healthcare professionals, the new Glooko clinic dashboard is based on TIDE (Timely Interventions for Diabetes Excellence) metrics to help address the challenge of managing a large diabetes patient population. This user-friendly view provides at-a-glance insights into patient population trends and key clinic metrics, making it easier for the entire care team to interpret complex data and guide more efficient decision-making and clinic strategy.

Built on TIDE Metrics for Smarter Diabetes Care

Leveraging evidence-based risk identification logic developed by Stanford researchers to further enhance clinical insights, personalize care, and demonstrate scalable, cost-effective outcomes, the TIDE dashboard, which demonstrated in a 2022 study to reduce screen time for healthcare providers reviewing patient data by 86%, is a powerful tool designed to help clinical teams manage large populations of patients with type 1 diabetes.

The TIDE dashboard uses smart algorithms to analyze and remotely monitor data from continuous glucose monitoring (CGM) devices, helping care teams efficiently and effectively manage their patients’ health. Using essential glucose measures like Time in Range and hypoglycemia, the TIDE model also prioritizes which patients need immediate attention by sorting them by clinical risk, so healthcare providers can focus on those who need it most without sifting through every patient’s data individually.

The TIDE model-based Glooko clinic dashboard offers our professional users a user-friendly way to tackle the challenge of managing a large patient population with three intuitive sections.

Understand Patient Population At-A-Glance

The Population Metrics section of the new Glooko clinic dashboard helps care teams understand the overall health and engagement of their clinic’s patient population in a centralized and concise view. This space displays the total number of patients with diabetes, identifies who is actively monitoring their blood glucose by blood glucose monitors (BGM) or CGM, and shows which patients have completed their Glooko account registration and are actively syncing their health data remotely with our connected care platform.

By centralizing these metrics, this comprehensive section of the dashboard helps healthcare providers shape clinic strategy more efficiently and better understand which patients to contact to activate their Glooko account to make more informed decisions based on synced health data.

Prioritize Care Based on Key CGM Metrics

The CGM Patient Risk Stratification section of the new Glooko clinic dashboard helps healthcare providers prioritize patient care and gives care teams a streamlined view of their patient population, sorted by clinical risk based on key glucose metrics from CGMs. Care teams can easily spot which patients need attention first. The dashboard ranks patients using indicators like Time in Range, Time Below Range, and other key CGM indicators, so healthcare providers can prioritize outreach and interventions based on the most important CGM data, making it easier for them to focus their time on the patients who need it most.

Boost Patient Engagement and Optimize Care

The Engagement Metrics module of the new Glooko clinic dashboard helps healthcare providers spot engagement gaps in their patient population over the past 90 days.

The Patient Account Status section examines the patient population to see if they’ve set-up their Glooko account based on Activated, Invited Pending, Never Invited, and Likely Duplicates. With these key metrics, care teams can quickly see which patients with diabetes haven’t completed the sync to Glooko with their diabetes and health monitoring devices as well as the activation process, allowing for more efficient follow-up and activation.

In the Sync Methods section, care teams can see how patients with diabetes are syncing their data with Glooko. When more health data is synced with Glooko from the cloud, Glooko Mobile App, Transmitter, or Uploader, care teams can make more informed and timely treatment decisions.

Experience Glooko’s New Clinic Dashboard

Ready to see how the intuitive, new Glooko clinic dashboard can optimize diabetes population health management at your clinic, hospital, or health system? Contact our team for a demo.

Unlock the full potential of the Glooko diabetes management platform in this comprehensive webinar led by Glooko Senior Director of Clinical Transformation Trisha Martinez, BSN, MBA, RN.

From foundational basics to advanced analytics, this session provides new users and seasoned professionals with a deep dive into the tools and features specifically built to enhance the diabetes management and care experience for healthcare providers and their patients with diabetes.

Our clinical expert also demonstrates how to leverage Glooko’s broad device compatibility to bridge data gaps. By transforming disconnected data into actionable insights across an entire patient population, healthcare providers can optimize clinical workflows and deliver elevated, data-driven patient care.

Manage your Diabetes Patient Population with New Depth

Schedule a one-on-one session with Team Glooko today to learn how to turn disconnected diabetes data into meaningful care and improved experiences for patients and healthcare providers.

Looking for more Glooko tips and tricks? Visit our Help Center.

MKT-0546

Today marks an important milestone in our mission to transform diabetes care. I am excited to share that Glooko has acquired Monarch Medical Technologies, creators of the EndoTool® Glucose Management System.

With this acquisition, Glooko is positioned to become the only diabetes management company with the potential to connect the full continuum of care — from home to hospital and back again. By bringing together EndoTool’s proven inpatient insulin dosing technology with Glooko’s leading outpatient platform, we aim to create a future where care is seamless, safer, and more supportive for both people living with diabetes and healthcare providers.

For patients, this means fewer disruptions as they move between settings, reduced risk of dangerous glycemic events, and more confidence that their care is connected. For healthcare providers, it means access to tools that simplify complex insulin management, standardize protocols, and free up time to focus on what matters most, which is caring for people.

This step also sets the foundation for Glooko’s future: using data and AI to help clinicians anticipate risks earlier, personalize care at scale, and improve outcomes under value-based models. By aligning advanced technology with clinical guidelines and EHR workflows, we can help hospitals and health systems deliver higher-quality care while lowering costs.

Our mission has always been clear: to simplify diabetes management, strengthen connections across the care team, and improve lives. This acquisition represents an important stride toward that vision.

Together, we are building a future where diabetes care is more connected, proactive, and patient-centered than ever.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.

We’re excited to announce the latest updates to Glooko Web 25.2 and Mobile 6.12, which are designed to help healthcare providers and people with diabetes by streamlining workflows, providing a new population management dashboard to triage at-risk patients and review population-level metrics, improving data visualizations, and giving care teams more powerful data from compatible devices to enhance diabetes management.

Introducing the New Clinic Dashboard

In this release, we launched a new clinic dashboard in the U.S. designed to give healthcare professionals at-a-glance insights into population health trends and clinic management metrics. This enhancement makes it easier to interpret complex data and guide decisions and clinic strategy more efficiently across care teams.

Other new clinic dashboard highlights include:

• Population Metrics: This section gives a single, concise, and organized view of the clinic’s total patient population, patients monitoring blood glucose, and those with activated accounts using key engagement and monitoring metrics.
• CGM Patient Risk Stratification: This dashboard, modeled after the Timely Interventions for Diabetes Excellence (TIDE) Dashboard, gives healthcare providers a streamlined view of their patient population, ranked by risk level using key glucose metrics and CGM data only. Care teams can identify risk levels using Time in Range, Time Below Range, and other key CGM indicators to prioritize care.
• Engagement Metrics: This section helps healthcare providers spot engagement gaps within their patient population over the past 90 days and take action to get more patients connected and syncing their devices with Glooko. With more synced health data, care teams can make more informed treatment decisions.

Banner Notification for Missing MRN

Glooko’s connected care platform prioritizes deep EHR integration to bring actionable diabetes data into the systems clinicians already use. To help maintain EHR data integrity and ensure patient matching is seamless, Glooko introduced a clear dismissible banner on the patient dashboard to notify clinicians when a Medical Record Number (MRN) is required but missing.

Tandem Basal Profile Switches

A new icon in DayView and WeekView on the Glooko diabetes management platform identifies when a patient changes their Tandem Personal Profile to give better context for insulin delivery.

GLP-1 Dose Enhancements

GLP-1 doses will now be displayed in the Glooko Web and Mobile software with improved messaging and clinical disclaimers. Healthcare professionals will now receive relevant dose range notifications while also providing precise dose information to support better oversight and patient adherence, while patients will see exact GLP-1 doses up to two decimal places as injected.

Device Type Display in PDFs

Glooko will now display controller device types in the PDF Settings Report, helping clinicians more clearly understand where data originated for users of Omnipod® 5 and other select devices. The report will specifically say on a clear device label the upload method (e.g., Android, iOS, Locked Down Controller) used by the patient.

Updated Insulin Statistics Design

The Glooko Mobile App’s insulin card has been redesigned to enhance clarity and consistency, particularly benefiting users with insulin pump data. This update aims to improve the understanding of insulin averages and minimize confusion between pump and total insulin values by displaying data in one unified insulin card.

More Information on the Latest Glooko Release

For more detailed information about these new features intended to enhance clinical practices and transform diabetes, be sure to check the full release notes on our Glooko Support page.

The NHS’s ambitious “Fit for the Future: 10 Year Health Plan for England” outlines a bold vision for the future of healthcare in the country — one that is digitally advanced, community-focused, and prevention-driven. It’s a plan designed to move healthcare from a reactive, hospital-centric model to a proactive, patient-empowering system utilising cutting-edge technologies. Within this transformative agenda, Glooko’s diabetes management platform stands out as an excellent example of how digital health solutions can directly support these crucial goals.

From Analogue to Digital: Empowering Patients and Streamlining Care

At the heart of the NHS’s plan is a commitment to becoming “digital by default.” This means harnessing technology to make healthcare more accessible, efficient, and patient-friendly.

Imagine a world where your health data, whether from your BGM, CGM, insulin pen, or activity tracker, is all in one place. That’s what Glooko offers through its integrations with more than 200 diabetes and health monitoring devices, including wearables, a future standard in the NHS by 2035. By centralising this vital information, it empowers people living with diabetes to take a more active role in managing their diabetes and saves them time by not having to juggle multiple apps or manually record readings.

For healthcare professionals, Glooko centralises health data from their patients into a single platform, helping create the “single, secure and authoritative account of their data” that the NHS aims for. To help reduce time-wasting administrative tasks, streamline workflows, and allow clinicians to have more efficient appointments focused on providing quality care, Glooko is expanding its capability to sync with electronic health record (EHR) systems across England and the rest of Europe. When all the relevant data is at their fingertips and seamlessly flowing between clinical records and the Glooko platform, everyone on the care team, including diabetologists, diabetes specialist nurses, registered dietitians, and general practitioners, can make more informed clinical decisions using our diabetes technology.

With our commitment to safeguarding confidential personal information and handling patient data properly, our diabetes management platform and our company’s practices meet the NHS’s data security standards outlined in the Data Security and Protection Toolkit. We align with the NHS’s requirements for all organisations with access to their patient data and systems.

From Hospital to Community: Enabling Remote Monitoring and Personalised Care

The NHS plan emphasises shifting care away from hospitals and into local communities and even patients’ homes. Glooko is instrumental in making this a reality for diabetes care with its remote patient monitoring capabilities.

This innovative feature of our diabetes software for healthcare providers means fewer trips to the hospital for routine check-ups and more proactive management of diabetes from the comfort of a patient’s home. This not only improves convenience for people living with diabetes but also helps to alleviate pressure on acute hospital services and supports the development of community-based models like “Neighbourhood Health Centres.”

The Glooko connected care platform offers powerful population health analytics. This allows hospitals to view trends and manage their entire patient population more effectively, aligning with the NHS’s goal of preventing illness and managing long-term conditions on a larger scale. The detailed insights provided by Glooko’s data can also support the creation and monitoring of highly personalised care plans, moving closer to the NHS’s goal of offering personal health budgets and tailored support for complex needs like diabetes.

From Sickness to Prevention: Proactive Management and Improved Outcomes

A core tenet of the NHS’s 10 Year Health Plan is a strong focus on prevention and early intervention.

By providing continuous diabetes and related health data and insights, Glooko helps healthcare providers identify potential issues and risks before they escalate. This allows for proactive intervention, which can significantly reduce the likelihood of diabetes-related complications, improving long-term health for patients.

And Glooko isn’t just about data; it’s about demonstrable results. The diabetes management platform has a track record of improving clinical outcomes, including reduced HbA1c levels. These outcomes directly align with the NHS’s aspirations for better health for the population, reduced demand on acute services, and a more sustainable healthcare system.

A Healthier Future for People with Diabetes

We want the NHS 10 Year Health Plan to deliver real improvements for people with diabetes and their care teams. Glooko is more than a diabetes management tool; we’re a strategic partner committed to helping the NHS deliver better care for all patients regardless of wherever they live and whatever they earn.

By accelerating digital transformation, enabling care at home, and championing proactive diabetes management, Glooko is helping build a more efficient, patient-centered, and digitally advanced healthcare system.

With innovative solutions and preferred vendors like Glooko, the NHS is well-equipped to meet the challenges and opportunities ahead as they usher in the future of healthcare in England.